Ibuprofen Medical Valley (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. Lower prostaglandin levels reduce the sensitisation of pain receptors, lower the hypothalamic set‑point for temperature, and limit the inflammatory response, resulting in analgesic, antipyretic, and anti‑inflammatory effects.

The appropriate dose of Ibuprofen Medical Valley is determined by the prescribing clinician based on the patient’s age, weight, condition being treated, and overall health status. Dosage recommendations are individualized and should follow the prescriber’s instructions and any applicable regulatory guidelines.

Ibuprofen is generally avoided in the third trimester of pregnancy because it may affect fetal cardiovascular development. Use during earlier pregnancy or while breastfeeding should be discussed with a healthcare provider, who will weigh potential benefits against any possible risks to the mother and child.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Ibuprofen shares a similar mechanism of action with other non‑steroidal anti‑inflammatory drugs, providing analgesic, antipyretic, and anti‑inflammatory benefits. Compared with some NSAIDs, ibuprofen has a relatively short half‑life, which may allow for flexible dosing but also requires regular administration for sustained effect. Safety profiles are comparable, though individual patient factors influence the choice of agent.

Ibuprofen Medical Valley should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it away from direct sunlight or heat sources to maintain stability and potency.

Ibuprofen Medical Valley is administered orally. The tablet or capsule should be swallowed whole with a full glass of water, preferably with food or milk to minimise gastrointestinal irritation, unless the prescriber advises otherwise.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe allergic reactions such as anaphylaxis, and hepatotoxicity. Patients with a history of ulcers, renal impairment, or cardiovascular disease should be monitored closely, and any signs of serious adverse events require immediate medical attention.

Ibuprofen Medical Valley should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients in the third trimester of pregnancy, and individuals with severe renal or hepatic impairment unless specifically directed by a physician.